Structure | Chemical Name | CAS | MF |
|
IKA(R) sieves for MF10 grinder
|
|
|
|
IKA(R) stone shaker
|
|
|
|
IKA(R) sieves for MF10 grinder
|
|
|
|
IKA(R) ULTRA-TURRAX(R) dispersing tools
|
|
|
|
IKA(R) ULTRA-TURRAX(R) homogenizer
|
|
|
|
IKA(R) universal attachment for KS shakers
|
|
|
|
IKARUGAMYCIN
|
36531-78-9
|
C29H38N2O4
|
|
IKA(R) VORTEX Genius attachments
|
|
|
|
IKA(R) VORTEX Genius inserts
|
|
|
|
IKA(R) Vibrax(R) orbital shaker attachment
|
|
|
|
IKA(R) Vibrax(R) Model VXR orbital shaker
|
|
|
|
IKA TEST TUBE ATTACHMENT, FOR VXR ORBITA L SHAKERS
|
|
|
|
IKCa1 channel
|
|
|
|
IKATRON(R) ETS D4 electronic thermometer
|
|
|
|
IkB Kinase Inhibitor Peptide, Cell-Permeable
|
|
|
|
IkB Kinase Inactive Control Peptide, Cell-Permeable
|
|
|
|
IKBL protein
|
|
|
|
IIVP-16
|
|
|
|
IKe gene 5 protein
|
|
|
|
IKe gene 3 protein
|
|
|
|
IKF 309
|
688046-61-9
|
C18H20ClNO5
|
|
IKF 309-13C,d3
|
1794979-50-2
|
C18H20ClNO5
|
|
ikhant
|
|
|
|
il40
|
1224-08-4
|
C15H13N3O2
|
|
IL-18
|
|
|
|
IKI3 family protein
|
|
|
|
Ikirara protein
|
|
|
|
IKK-ALPHA (C2), HUMAN
|
|
C75H121N21O33S
|
|
IKK-ALPHA CONTROL PEPTIDE
|
|
C92H146N32O26S
|
|
IKK-ALPHA (C3), HUMAN
|
|
C62H108N20O26
|
|
IKKALPHA(C3),IKAPPABKINASEALPHA,RABBITANTI-HUMAN:WB
|
|
|
|
IKKALPHA(C2),IKAPPABKINASEALPHA,RABBITANTI-HUMAN:WB
|
|
|
|
IKKALPHA(C1),AA716-734,IKAPPABKINASEALPHA,RABBITANTI-HUMAN:WB
|
|
|
|
IKKalpha (Ab-1) Monoclonal Antibody *FROZEN
|
|
|
|
(131)I-labeled diazeniumdiolated albumin
|
|
|
|
IKKBETA(C3),IKAPPABKINASEBETA,RABBITANTI-HUMAN:WB
|
|
|
|
IKKbeta (Ab-1) Monoclonal Antibody *FROZEN
|
|
|
|
125I-LABELLED STREPTAVIDIN
|
|
|
|
IKK-BETA CONTROL PEPTIDE
|
|
C63H98N18O30S
|
|
IKK-BETA
|
|
|
|
IL-8 Accucyte(R) EIA Kit, Human
|
|
|
|
IkkComplexAssociatedProtein(Ikap)
|
|
|
|
IKKEPSILON(CT),IKAPPABKINASEEPSILON,RABBITANTI-HUMAN:WB
|
|
|
|
IKKGAMMA(NT),IKAPPABKINASEGAMMA,NEMO,RABBITANTI-HUMAN,MOUSE,RAT:WB
|
|
|
|
IL-1A, HUMAN
|
|
|
|
IKK-i kinase
|
|
|
|
IKK Inhibitor III, BMS-345541
|
445430-58-0
|
C14H17N5
|
|
IKK-2 INHIBITOR IV
|
|
C12H10FN3O2S
|
|
IL-1ALPHA PRIMER PAIR
|
|
|
|
IL-1ALPHA (223-250) (HUMAN)
|
|
C158H219N37O44
|
|
IKK-NBD CONTROL PEPTIDE
|
|
|
|
IKK-NBD PEPTIDE
|
|
|
|
IL-1 b Converting Enzyme: ICE Substrate II
|
|
|
|
IKKε Monoclonal Antibody (Clone 72B587)
|
|
|
|
IKKγ Monoclonal Antibody (Clone 72C627)
|
|
|
|
IKKγ Monoclonal Antibody (Clone 46B844)
|
|
|
|
IKKα Monoclonal Antibody (Clone 14A231)
|
|
|
|
IL-1BETA (208-240) (HUMAN)
|
|
|
|
IL-1BETA,MABANTI-
|
|
|
|
IL-beta Inhibitor
|
|
|
|
IL-3-BETA, RAT
|
|
|
|
IL-1BETA (178-207) (HUMAN)
|
|
C157H256N38O49S
|
|
IL-1BETA PRIMER PAIR
|
|
|
|
IKKε Polyclonal Antibody
|
|
|
|
IKLF protein
|
|
|
|
Ilaprazole
|
|
|
|
ILA receptor
|
|
|
|
IL-22 binding protein
|
|
|
|
Ilatreotide
|
|
|
|
IL-1B, MOUSE
|
|
|
|
IL-18 BP, MOUSE
|
|
|
|
Ile-ala-tyr-lys-pro-glu-NH2
|
133337-28-7
|
C34H54N8O9
|
|
[Ile34]-β- Amyloid (25 - 34)
|
|
|
|
Ile-Arg-Ile-Cys(Me)-Arg-Lys-Gly-NH2
|
|
|
|
ILE-ARG-ILE-LEU-GLN-GLN-LEU-LEU-PHE-ILE-HIS-PHE-ARG-ILE
|
|
C88H144N24O17
|
|
ILDLWKAIDGLPYSRSPRMT
|
|
|
|
ILE-GLY-GLY
|
68293-03-8
|
C10H19N3O4
|
|
ILE-GLU-SER-ILE-PRO-ASP-PRO-PRO-THR-ASN-THR-PRO-GLU-ALA-LEU
|
|
C70H112N16O26
|
|
ILE-GLN-LYS-GLU-ILE-ASP-ARG-LEU-ASN-GLU-VAL-ALA-LYS-ASN-LEU-ASN-GLU-SER- LEU-ILE
|
|
|
|
ILE-GLU-THR-VAL-PRO-VAL-LYS-LEU-LYS-PRO-GLY-MET-ASP-GLY-PRO-LYS-VAL-LYS-GLN-TRP-PRO-LEU-THR-GLU-GLU
|
|
C129H211N31O37S
|
|
ILE-GLY-VAL-THR-GLN-GLN-ARG-ARG-ALA-ARG-ASN-GLY-ALA-SER-ARG-SER
|
|
C69H125N31O23
|
|
ILE-GLY-ARG-ASN-LEU-LEU-THR-GLN-ILE-GLY-CYS-THR-LEU-ASN-PHE
|
|
C73H123N21O21S
|
|
IKP 104
|
114231-14-0
|
C26H21ClFNO3
|
|
ILE-HIS-SER-ILE-SER-GLU-ARG-ILE-LEU-SER-THR-TYR-LEU
|
|
C69H114N18O21
|
|
COUMARONE RESIN
|
63393-89-5
|
|
|
Ile-isoindoline hydrochloride salt
|
1056413-18-3
|
C14H20N2O
|
|
ILE-LEU-LYS-LYS-ASP-VAL-ILE-VAL-GLN-ASP-ASP-ASP-VAL-ASP HUMAN, RAT, BOVINE
|
|
C70H119N17O26
|
|
ILE-LEU-VAL-GLU-SER-PRO-THR-VAL-LEU-GLU-SER-GLY-THR-LYS-GLU
|
|
C70H120N16O26
|
|
ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU
|
|
C59H89N13O10
|
|
ILE-LEU-ASN-GLY-ILE-ASN-ASN-TYR-LYS-ASN-PRO-LYS-LEU
|
|
C68H113N19O19
|
|
ILE-LEU-ALA-GLN-GLN-GLU-ALA-VAL-GLU-GLY-GLY-CYS
|
|
|
|
[Ile161]MAGE - A2 (157-166)
|
|
|
|
IL-8, ENDOTHELIAL, HUMAN
|
|
|
|
IL-2:FC (NON-LYTIC)/FC CHIMERA
|
|
|
|
IL-4:FC (NON-LYTIC)/FC CHIMERA
|
|
|
|
IL-2:FC (NON-LYTIC) HUMAN/FC CHIMERA
|
|
|
|
IL-10:FC (NON-LYTIC) HUMAN/FC CHIMERA
|
|
|
|
IL-10:FC (NON-LYTIC)/FC CHIMERA
|
|
|
|
ILE-LYS-ILE-GLY-GLY-GLN-LEU-LYS-GLU-ALA-LEU-LEU-ASP-THR-GLY
|
|
C69H122N18O22
|
|
ILE-LYS-VAL-ALA-VAL
|
|
C25H48N6O6
|